New powdered plasma passes early safety check in healthy volunteers
NCT ID NCT05629338
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 29 times
Summary
This early-stage study tested the safety of a new spray-dried plasma product called FrontlineODP in 24 healthy adults. Participants received one, two, or four units of the product, and their safety was compared to those receiving standard frozen plasma. The goal was to see if the product is safe enough to move forward in development for treating bleeding and clotting problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMORRHAGE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hoxworth Blood Center
Cincinnati, Ohio, 45267-0055, United States
-
Spaulding Clinical Research LLC
West Bend, Wisconsin, 53095, United States
-
Versiti Blood Center of Wisconsin
Milwaukee, Wisconsin, 53233, United States
Conditions
Explore the condition pages connected to this study.